High-flying tech and growth stocks were among the most popular assets of traders and investors in 2021. And as of late, there have been a number of clear winners between the assets.
Since January 2021, NVIDIA Corporation's (NASDAQ:NVDA) stock 1-year return has outperformed several of the world’s most popular stocks and cryptocurrencies: Tesla Inc (NASDAQ:TSLA), Microsoft Corporation (NASDAQ:MSFT), Apple Inc (NASDAQ:AAPL), Moderna Inc (NASDAQ:MRNA) and Riot Blockchain Inc (NASDAQ:RIOT).
Nvidia is a leading designer of graphics processing units that enhance the experience on computing platforms. The firm's chips are used in a variety of end markets, including high-end PCs for gaming, data centers and automotive infotainment systems.
In recent years, the firm has broadened its focus from traditional PC graphics applications such as gaming to more complex and favorable opportunities, including artificial intelligence and autonomous driving, which leverage the high-performance capabilities of the firm's graphics processing units.
Here's how the returns break down from January 2021 to the present:
Related Link: Why Nvidia Is Needham's Top AI/ML Stock Pick For 2022
For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We sift through the market for consistent trades so you don’t have to. Get Benzinga Options: Starter Edition to follow our high-conviction options trades.
Join thousands of stock investors who capture news events before they drive stock price changes.
© 2022 Benzinga | All Rights Reserved
Advertiser Disclosure: TD Ameritrade, Inc. and Accretive Capital LLC are separate, unaffiliated companies and are not responsible for each other’s services and products.
Editorial Disclosure: Reviews are as determined by Benzinga Money. Opinions expressed here are solely the author’s and have not been reviewed, approved or otherwise endorsed by reviewers.